Arete Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-8,036
| Closed | -$227M | – | 658 |
|
|
2022
Q4 | $227M | Buy |
8,036
+820
| +11% | +$23.1M | 0.02% | 530 |
|
|
2022
Q3 | $237K | Buy |
7,216
+281
| +4% | +$9.23K | 0.02% | 474 |
|
|
2022
Q2 | $219K | Buy |
6,935
+159
| +2% | +$5.02K | 0.02% | 410 |
|
|
2022
Q1 | $311K | Sell |
6,776
-746
| -10% | -$34.2K | 0.03% | 368 |
|
|
2021
Q4 | $473K | Buy |
7,522
+328
| +5% | +$20.6K | 0.04% | 296 |
|
|
2021
Q3 | $538K | Sell |
7,194
-58
| -0.8% | -$4.34K | 0.06% | 246 |
|
|
2021
Q2 | $519K | Buy |
7,252
+319
| +5% | +$22.8K | 0.07% | 200 |
|
|
2021
Q1 | $615K | Sell |
6,933
-9,969
| -59% | -$884K | 0.08% | 210 |
|
|
2020
Q4 | $1.58M | Buy |
16,902
+415
| +3% | +$38.7K | 0.22% | 101 |
|
|
2020
Q3 | $1.05M | Buy |
+16,487
| New | +$1.05M | 0.16% | 147 |
|